Neurochase

Pharmaceuticals - London, England, United Kingdom

Neurochase Senior Management
Sharon Kane

Chief Executive Officer

Contact Sharon Kane

Contact All Neurochase Employees
Neurochase Details

Drug-device combination therapies utilising convection-enhanced delivery (CED) are an emerging therapeutic strategy for the treatment of neurological disorders. When delivered via CED, biologics and chemotherapeutics can achieve homogeneous distribution within a targeted brain structure while avoiding systemic immunogenicity and off-target side effects. We believe that CED has the potential to transform human longevity by unlocking treatments to previously untreatable neurological disorders. At Neurochase, our goal is to develop the world's most comprehensive drug development process for CED therapeutics.

Neurochase logo, Neurochase contact details
Employees: 3
HQ: +44 7507 158943
Location: London, England, United Kingdom
Revenue:
Neurochase Technologies
Email Providers

Outlook

CMS

WordPress.org

Tag Management

Google Tag Manager

Social Login

Facebook Login (Connect)

Other

Microsoft Office 365

Hosting

Google Cloud Hosting

View All Technologies Used At Neurochase

Contacting Neurochase: Connect with Executives and Employees

Get in Touch with Neurochase Executives and Employees

Connecting with Neurochase's Executives and Workforce

Accessing Contact Information for Neurochase Executives

Connecting with Neurochase: Reach Out to Their Team

Discover How to Contact Neurochase Executives and Staff

Looking to connect with Neurochase executives or employees?

Seeking to Get in Touch with Neurochase Executives or Staff?

Want to Reach Out to Neurochase Executives or Team Members?

In Search of Contact Details for Neurochase Professionals?

Connecting with Neurochase: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z